SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XPEL, Inc. – XPEL
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of XPEL, Inc. (“XPEL” or the “Company”) (NASDAQ: XPEL). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 798
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GrafTech International Ltd. – EAF
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of GrafTech International Ltd. (“GrafTech” or the “Company”) (NYSE: EAF). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-4
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of John Wiley & Sons, Inc. – WLY
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of John Wiley & Sons, Inc. (“Wiley” or the “Company”) (NYSE: WLY). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476
Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
SAN DIEGO and ZUG, Switzerland, Nov. 3, 2023 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial stage biotechnology company, today announced the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) granted conditional marketing authorization app
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of R1 RCM Inc. – RCM
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of R1 RCM Inc. (“RCM” or the “Company”) (NASDAQ: RCM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tigo Energy, Inc. – TYGO
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Tigo Energy, Inc. (“Tigo” or the “Company”) (NASDAQ: TYGO). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
Maiello Brungo & Maiello, LLP Ranked by Best Law Firms® in 2024
MBM RANKED TOP TIER IN PITTSBURGH FOR REAL ESTATE LAWTIER 2: CONSTRUCTION LAW, EMPLOYMENT LAW – MANAGEMENT, LITIGATION -CONSTRUCTION PITTSBURGH, Nov. 3, 2023 /PRNewswire/ — Maiello Brungo & Maiello, LLP (MBM), has been recognized in the 2024 edition of Best Law Firms®, ranked by Best
Dover Board Elects Marc A. Howze as New Independent Director
DOWNERS GROVE, Ill., Nov. 3, 2023 /PRNewswire/ — Dover (NYSE: DOV) today announced that its Board of Directors has elected Marc A. Howze as a new independent director effective immediately. Mr. Howze’s appointment increases the size of the Board to 11 directors, 10 of whom are independen
Canadian Investment Regulatory Organization Trade Resumption – ICY.P
VANCOUVER, BC, Nov. 3, 2023 /CNW/ – Trading resumes in: Company: Iocaste Ventures Inc. TSX-Venture Symbol: ICY.P All Issues: Yes Resumption (ET): 9:30 AM 11/6/2023 CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading ha
UK-based Global Education Holdings acquires Schiller International University
LONDON, Nov. 3, 2023 /PRNewswire/ — UK-based educational group Global Education Holdings (GEDU) has acquired the Schiller International University of USA. Schiller is the first American University with multiple campuses in Europe. With this acquisition, GEDU has expanded to the US market, embo
